Soyombo Abigail A, Tjon-Kon-Sang Sandra, Rbaibi Youssef, Bashllari Enkelejda, Bisceglia Jill, Muallem Shmuel, Kiselyov Kirill
Department of Physiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.
J Biol Chem. 2006 Mar 17;281(11):7294-301. doi: 10.1074/jbc.M508211200. Epub 2005 Dec 16.
Mucolipidosis type IV (MLIV) is caused by mutations in the ion channel mucolipin 1 (TRP-ML1). MLIV is typified by accumulation of lipids and membranous materials in intracellular organelles, which was hypothesized to be caused by the altered membrane fusion and fission events. How mutations in TRP-ML1 lead to aberrant lipolysis is not known. Here we present evidence that MLIV is a metabolic disorder that is not associated with aberrant membrane fusion/fission events. Thus, measurement of lysosomal pH revealed that the lysosomes in TRP-ML1(-/-) cells obtained from the patients with MLIV are over-acidified. TRP-ML1 can function as a H(+) channel, and the increased lysosomal acidification in TRP-ML1(-/-) cells is likely caused by the loss of TRP-ML1-mediated H(+) leak. Measurement of lipase activity using several substrates revealed a marked reduction in lipid hydrolysis in TRP-ML1(-/-) cells, which was rescued by the expression of TRP-ML1. Cell fractionation indicated specific loss of acidic lipase activity in TRP-ML1(-/-) cells. Furthermore, dissipation of the acidic lysosomal pH of TRP-ML1(-/-) cells by nigericin or chloroquine reversed the lysosomal storage disease phenotype. These findings provide a new mechanism to account for the pathogenesis of MLIV.
IV型粘脂贮积症(MLIV)由离子通道粘脂蛋白1(TRP - ML1)的突变引起。MLIV的典型特征是细胞内细胞器中脂质和膜性物质的积累,据推测这是由膜融合和裂变事件改变所致。TRP - ML1的突变如何导致异常脂解尚不清楚。在此我们提供证据表明,MLIV是一种与异常膜融合/裂变事件无关的代谢紊乱疾病。因此,溶酶体pH值的测量显示,从MLIV患者获得的TRP - ML1(- / -)细胞中的溶酶体过度酸化。TRP - ML1可作为H(+)通道发挥作用,TRP - ML1(- / -)细胞中溶酶体酸化增加可能是由于TRP - ML1介导的H(+)泄漏丧失所致。使用几种底物测量脂肪酶活性显示,TRP - ML1(- / -)细胞中的脂质水解显著减少,而TRP - ML1的表达可使其恢复。细胞分级分离表明TRP - ML1(- / -)细胞中酸性脂肪酶活性特异性丧失。此外,尼日利亚菌素或氯喹使TRP - ML1(- / -)细胞酸性溶酶体pH值消散,逆转了溶酶体贮积病表型。这些发现为解释MLIV的发病机制提供了一种新机制。